Summary of Study ST002848

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001783. The data can be accessed directly via it's Project DOI: 10.21228/M87M7X This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  |  Perform analysis on untargeted data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002848
Study TitleLipidomics for linked CD1 proteins
Study SummaryIn this study, the four types of human CD1 antigen-presenting molecules were constructed using a protein linker between heavy chains of CD1 proteins and beta 2 macroglobulin (B2m), thus called linked CD1 proteins, expressed in human myelogenous cell line K562 cell, purified using affinity chromatography, and extracted using the adapted Folch method for bound lipids. These extracted lipids in triplicates from four CD1 proteins were profiled using the extraction from in parallel generated HLA-B27 protein as a control. Data demonstrated differing lipid capture motifs based on the length and chemical structures of lipids bound, pointing to general self-lipid capture mechanisms. For CD1a and CD1d, lipid size matches CD1 cleft volume, whereas CD1b shows a nearly universal size mismatch with its ligands, which results from the uniform seating of two small lipids within its large cleft. Further, the list of compounds that comprise the assembled CD1 lipidomes provides a resource for matching to bioactive lipids from other fields of research and supports the ongoing discovery of lipid blockers and antigens for T cells.
Institute
Brigham and Women's Hospital
Last NameHuang
First NameShouxiong
Address251 Kettering Laboratory Complex, 160 Panzeca Way, Cincinnati, OH
Emailshouxiong.huang@uc.edu
Phone5135587572
Submit Date2023-08-10
Raw Data AvailableYes
Raw Data File Type(s)mzdata.xml
Analysis Type DetailLC-MS
Release Date2023-11-10
Release Version1
Shouxiong Huang Shouxiong Huang
https://dx.doi.org/10.21228/M87M7X
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN004666
Analysis type MS
Chromatography type Normal phase
Chromatography system Agilent 1200
Column First through a MetaGuard guard column (2 mm, 3 μm, Varian, A0542-MG2) and then a MonoChrom Diol column (150 X 2 mm, 3μm, Varian, A0542150X020)
MS Type ESI
MS instrument type QTOF
MS instrument name Agilent 6520 QTOF
Ion Mode POSITIVE
Units 542

MS:

MS ID:MS004413
Analysis ID:AN004666
Instrument Name:Agilent 6520 QTOF
Instrument Type:QTOF
MS Type:ESI
MS Comments:Ionization occurred with a dual-electrospray ionization source maintained at 325°C with a drying gas flow of 5 L/min, nebulizer pressure of 30 pounds per square inch, and a capillary voltage of 5.5 kV. Positive- and negative-ion modes were typically monitored between m/z 100-3000 with the acquisition rate of 1.4 spectra/sec and 713.7 ms/spectrum. Internal calibrants (Agilent G1969-85001, m/z 121.050573, 922.009798) were continuously monitored to assess electrospray efficiency and mass accuracy. NanoESI-CID-MS was typically performed at a collision energy of 35V and an isolation width of 1.3 m/z and adjusted to optimize signal during individual experiments. MS data were acquired with MassHunter software.
Ion Mode:POSITIVE
Analysis Protocol File:CD1_lipidomics-090523.docx
  logo